Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HOLISTISK KURKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8%   Bankruptcy risk   12.8% 12.9% 7.7% 7.4% 5.1% 9.7% 15.9% 15.6%   Credit score (0-100)   19 19 31 32 42 24 12 12   Credit rating   BB BB BB BBB BBB BB BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   121 260 420 421 609 311 0.0 0.0   EBITDA   -87.8 75.1 128 95.5 211 -91.1 0.0 0.0   EBIT   -89.9 75.1 123 67.7 198 -106 0.0 0.0   Pre-tax profit (PTP)   -92.6 73.3 120.8 63.4 203.5 -108.3 0.0 0.0   Net earnings   -92.6 73.3 103.5 53.2 167.4 -108.3 0.0 0.0   Pre-tax profit without non-rec. items   -92.6 73.3 121 63.4 203 -108 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -77.7 -4.4 99.1 152 320 44.0 -81.0 -81.0   Interest-bearing liabilities   139 95.6 88.8 17.2 5.0 44.4 81.0 81.0   Balance sheet total (assets)   79.8 120 270 231 418 126 0.0 0.0   Net Debt   120 41.3 -85.4 -146 -217 -13.9 81.0 81.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   121 260 420 421 609 311 0.0 0.0   Gross profit growth   -29.2% 114.5% 61.2% 0.2% 44.8% -48.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   80 120 270 231 418 126 0 0   Balance sheet change%   -46.3% 50.5% 124.5% -14.3% 80.7% -69.7% -100.0% 0.0%   Added value   -87.8 75.1 127.6 95.5 225.6 -91.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -2 0 -5 -28 -13 -15 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -74.1% 28.9% 29.3% 16.1% 32.5% -34.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -58.8% 53.3% 62.4% 27.0% 63.0% -38.9% 0.0% 0.0%   ROI %   -69.9% 64.1% 86.8% 37.9% 82.8% -51.2% 0.0% 0.0%   ROE %   -195.5% 73.3% 94.4% 42.3% 70.9% -59.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -49.3% -3.5% 36.7% 65.9% 76.5% 34.8% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -136.4% 55.0% -66.9% -152.8% -102.7% 15.2% 0.0% 0.0%   Gearing %   -178.4% -2,179.0% 89.6% 11.3% 1.6% 101.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.2% 1.5% 2.5% 8.0% 10.0% 10.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.4 1.2 2.1 3.5 0.7 0.0 0.0   Current Ratio   0.2 0.6 1.3 2.4 3.8 1.0 0.0 0.0   Cash and cash equivalent   19.0 54.3 174.2 163.0 221.7 58.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -119.5 -46.2 57.3 110.5 277.9 2.2 -40.5 -40.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -88 75 128 95 226 -91 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -88 75 128 95 211 -91 0 0   EBIT / employee   -90 75 123 68 198 -106 0 0   Net earnings / employee   -93 73 104 53 167 -108 0 0